Reventa™
Therapeutic Segment:
Anti-Osteoporotic
Generic Name:
Alendronate sodium
Indication
Tablets
- 10MG
- 70MG
- In postmenopausal women for the treatment of osteoporosis to prevent fractures, including those of the hip and spine (vertebral compression fractures).
- In postmenopausal women who are at risk of developing osteoporosis.
- For the treatment of osteoporosis in men to prevent
fractures. - For the treatment and prevention of glucocorticoid-induced osteoporosis and for treatment of Paget’s disease in men and women.